Left atrial appendage occlusion devices versus pharmacological agents for stroke prevention in atrial fibrillation: testing the noninferiority margins

Free article

Comment

Andrea Messori et al. JACC Cardiovasc Interv. 2014 Aug.

Free article

. 2014 Aug;7(8):942-3.

doi: 10.1016/j.jcin.2014.04.008.

No abstract available

Comment in

Reply: Left atrial appendage occlusion devices versus pharmacological agents for stroke prevention in atrial fibrillation: testing the noninferiority margins.
Parashar A, Agarwal S, Bajaj NS, Tuzcu EM, Kapadia SR. Parashar A, et al. JACC Cardiovasc Interv. 2014 Aug;7(8):943. doi: 10.1016/j.jcin.2014.05.010. JACC Cardiovasc Interv. 2014. PMID: 25147043 No abstract available.

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Ruff CT, et al. Lancet. 2014 Mar 15;383(9921):955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4. Lancet. 2014. PMID: 24315724
Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies.
Bajaj NS, Parashar A, Agarwal S, Sodhi N, Poddar KL, Garg A, Tuzcu EM, Kapadia SR. Bajaj NS, et al. JACC Cardiovasc Interv. 2014 Mar;7(3):296-304. doi: 10.1016/j.jcin.2013.11.010. JACC Cardiovasc Interv. 2014. PMID: 24650403